조영제 시장 규모, 점유율 및 동향 분석 보고서 : 모달리티별, 제품별, 용도별, 투여 경로별, 최종 용도별, 지역별, 부문 예측(2026-2033년)

Contrast Media Market Summary

The global contrast media market size was estimated at USD 7.31 billion in 2025 and is projected to reach USD 13.86 billion by 2033, growing at a CAGR of 8.39% from 2026 to 2033. The demand for contrast media is rising owing to the growing need for medical imaging and the rising burden of chronic disorders.

High volume of imaging procedures, such as ultrasound and MRI scans, is anticipated to support the market growth. The growing global demand for medical imaging is a key factor driving the expansion of the contrast media market. Medical imaging plays a crucial role in the early detection, accurate diagnosis, and effective treatment planning of various health conditions. Millions of patients undergo diagnostic procedures such as MRI, CT scans, and X-rays every year. According to a study published by the National Library of Medicine in October 2023, approximately 40 million MRI scans are performed annually in the U.S. alone. The increasing volume of imaging procedures worldwide is expected to significantly boost the demand for contrast media, essential for enhancing the visualization of internal body structures during these examinations.

Beyond the U.S., other countries are also experiencing a rising demand for medical imaging procedures. According to data published by the Australian Institute of Health & Welfare (AIHW) in July 2024, 10.2 million Australians accessed Medicare-subsidized diagnostic imaging services in 2022-23, while approximately 4.0 million used other diagnostic services. This upward trend is expected to continue in the coming years, further contributing to the growing global demand for contrast media used in diagnostic imaging.

Global Contrast Media Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis on the latest industry trends in each of the sub-segments from 2021 to 2033. For the purpose of this study, Grand View Research has segmented the global contrast media market report based on product, modality type, application, route of administration, end use, and region:

• Modality Outlook (Revenue, USD Million, 2021 - 2033)
• Ultrasound
• Magnetic Resonance Imaging
• X-ray/Computed Tomography
• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Microbubble
• Gadolinium-Based
• Iodinated
• Barium-Based
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Cardiovascular Disorders
• Neurological Disorders
• Gastrointestinal Disorders
• Cancer
• Nephrological Disorders
• Musculoskeletal Disorders
• Others
• Route of Administration Outlook (Revenue, USD Million, 2021 - 2033)
• Intravenous
• Oral Route
• Rectal Route
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals
• Diagnostic Imaging Centers
• Others
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Product
  • 1.1.2. Modality
  • 1.1.3. Application
  • 1.1.4. Route Of Administration
  • 1.1.5. End use
  • 1.1.6. Regional scope
  • 1.1.7. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.1.1. Approach 1: Commodity flow approach
  • 1.6.2. Volume price analysis (Model 2)
    • 1.6.2.1. Approach 2: Volume price analysis
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives
  • 1.9.1. Objective 1
  • 1.9.2. Objective 2

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Contrast Media Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Increasing demand for medical imaging
    • 3.2.1.2. Approvals and launches of contrast media agents
    • 3.2.1.3. Increasing disease burden
    • 3.2.1.4. Technological advancements
    • 3.2.1.5. Rising production capacities for contrast media
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Recalls of contrast media
    • 3.2.2.2. Shortage of Iohexol and Iodixanol
  • 3.2.3. Market opportunity analysis
    • 3.2.3.1. Development of interconnected solutions in contrast agents
    • 3.2.3.2. Growing number of clinical trials
    • 3.2.3.3. Improvements in public and private healthcare infrastructure
    • 3.2.3.4. Growth potential in emerging economies in contrast media market
  • 3.2.4. Market challenge analysis
    • 3.2.4.1. Potential complications and risks associated with contrast media
• 3.3. Contrast Media Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political & Legal Landscape
    • 3.3.2.2. Economic and Social Landscape
    • 3.3.2.3. Technological landscape

Chapter 4. Contrast Media Market: Modality Type Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Contrast Media Market Modality Type Movement Analysis
• 4.3. Global Contrast Media Market Size & Trend Analysis, by Modality Type, 2021 to 2033 (USD Million)
• 4.4. Ultrasound
  • 4.4.1. Ultrasound market estimates and forecasts for 2021 to 2033 (USD Million)
• 4.5. Magnetic Resonance Imaging
  • 4.5.1. Magnetic resonance imaging market estimates and forecasts for 2021 to 2033 (USD Million)
• 4.6. X-ray/Computed Tomography
  • 4.6.1. X-ray/computed tomography market estimates and forecasts for 2021 to 2033 (USD Million)

Chapter 5. Contrast Media Market: Product Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Contrast Media Market Product Movement Analysis
• 5.3. Global Contrast Media Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
• 5.4. Microbubble
  • 5.4.1. Microbubble market estimates and forecasts for 2021 to 2033 (USD Million)
• 5.5. Gadolinium-Based
  • 5.5.1. Gadolinium-based market estimates and forecasts for 2021 to 2033 (USD Million)
• 5.6. Iodinated
  • 5.6.1. Iodinated market estimates and forecasts for 2021 to 2033 (USD Million)
• 5.7. Barium-based
  • 5.7.1. Barium-based market estimates and forecasts for 2021 to 2033 (USD Million)

Chapter 6. Contrast Media Market: Application Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global Contrast Media Market Application Movement Analysis
• 6.3. Global Contrast Media Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
• 6.4. Cardiovascular Disorders
  • 6.4.1. Cardiovascular disorders market estimates and forecast 2021 to 2033 (USD Million)
• 6.5. Neurological Disorders
  • 6.5.1. Neurological disorders market estimates and forecast 2021 to 2033 (USD Million)
• 6.6. Gastrointestinal Disorders
  • 6.6.1. Gastrointestinal disorders market estimates and forecast 2021 to 2033 (USD Million)
• 6.7. Cancer
  • 6.7.1. Cancer market estimates and forecast 2021 to 2033 (USD Million)
• 6.8. Nephrological Disorders
  • 6.8.1. Nephrological disorders market estimates and forecast 2021 to 2033 (USD Million)
• 6.9. Musculoskeletal Disorders
  • 6.9.1. Musculoskeletal disorders market estimates and forecast 2021 to 2033 (USD Million)
• 6.10. Others
  • 6.10.1. Others market estimates and forecast 2021 to 2033 (USD Million)

Chapter 7. Contrast Media Market: Route of Administration Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Global Contrast Media Market Route Of Administration Movement Analysis
• 7.3. Global Contrast Media Market Size & Trend Analysis, by Route Of Administration, 2021 to 2033 (USD Million)
• 7.4. Intravenous
  • 7.4.1. Intravenous market estimates and forecast 2021 to 2033 (USD Million)
• 7.5. Oral Route
  • 7.5.1. Oral route market estimates and forecast 2021 to 2033 (USD Million)
• 7.6. Rectal Route
  • 7.6.1. Rectal route market estimates and forecast 2021 to 2033 (USD Million)

Chapter 8. Contrast Media Devices: End Use Estimates & Trend Analysis

• 8.1. Segment Dashboard
• 8.2. Global Contrast Media Market End Use Movement Analysis
• 8.3. Global Contrast Media Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
• 8.4. Hospitals
  • 8.4.1. Hospitals market estimates and forecasts for 2021 to 2033 (USD Million)
• 8.5. Diagnostic Imaging Centers
  • 8.5.1. Diagnostic imaging centers market estimates and forecasts for 2021 to 2033 (USD Million)
• 8.6. Others
  • 8.6.1. Others market estimates and forecasts for 2021 to 2033 (USD Million)

Chapter 9. Contrast Media Market: Regional Estimates & Trend Analysis By Product, By Modality, By Application, By Route of Administration, By End Use

• 9.1. Regional Dashboard
• 9.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
• 9.3. North America
  • 9.3.1. Market estimates and forecast, 2021 - 2033 (Revenue, USD Million)
  • 9.3.2. U.S.
    • 9.3.2.1. Key country dynamics
    • 9.3.2.2. Competitive scenario
    • 9.3.2.3. Regulatory framework
    • 9.3.2.4. Reimbursement scenario
    • 9.3.2.5. U.S. market estimates and forecasts, 2021 - 2033
  • 9.3.3. Canada
    • 9.3.3.1. Key country dynamics
    • 9.3.3.2. Competitive scenario
    • 9.3.3.3. Regulatory framework
    • 9.3.3.4. Reimbursement scenario
    • 9.3.3.5. Canada market estimates and forecasts, 2021 - 2033
  • 9.3.4. Mexico
    • 9.3.4.1. Key country dynamics
    • 9.3.4.2. Competitive scenario
    • 9.3.4.3. Regulatory framework
    • 9.3.4.4. Reimbursement scenario
    • 9.3.4.5. Mexico market estimates and forecasts, 2021 - 2033
• 9.4. Europe
  • 9.4.1. UK
    • 9.4.1.1. Key country dynamics
    • 9.4.1.2. Competitive scenario
    • 9.4.1.3. Regulatory framework
    • 9.4.1.4. Reimbursement scenario
    • 9.4.1.5. UK market estimates and forecasts, 2021 - 2033
  • 9.4.2. Germany
    • 9.4.2.1. Key country dynamics
    • 9.4.2.2. Competitive scenario
    • 9.4.2.3. Regulatory framework
    • 9.4.2.4. Reimbursement scenario
    • 9.4.2.5. Germany market estimates and forecasts, 2021 - 2033
  • 9.4.3. France
    • 9.4.3.1. Key country dynamics
    • 9.4.3.2. Competitive scenario
    • 9.4.3.3. Regulatory framework
    • 9.4.3.4. Reimbursement scenario
    • 9.4.3.5. France market estimates and forecasts, 2021 - 2033
  • 9.4.4. Italy
    • 9.4.4.1. Key country dynamics
    • 9.4.4.2. Competitive scenario
    • 9.4.4.3. Regulatory framework
    • 9.4.4.4. Reimbursement scenario
    • 9.4.4.5. Italy market estimates and forecasts, 2021 - 2033
  • 9.4.5. Spain
    • 9.4.5.1. Key country dynamics
    • 9.4.5.2. Competitive scenario
    • 9.4.5.3. Regulatory framework
    • 9.4.5.4. Reimbursement scenario
    • 9.4.5.5. Spain market estimates and forecasts, 2021 - 2033
  • 9.4.6. Denmark
    • 9.4.6.1. Key country dynamics
    • 9.4.6.2. Competitive scenario
    • 9.4.6.3. Regulatory framework
    • 9.4.6.4. Reimbursement scenario
    • 9.4.6.5. Denmark market estimates and forecasts, 2021 - 2033
  • 9.4.7. Sweden
    • 9.4.7.1. Key country dynamics
    • 9.4.7.2. Competitive scenario
    • 9.4.7.3. Regulatory framework
    • 9.4.7.4. Reimbursement scenario
    • 9.4.7.5. Sweden market estimates and forecasts, 2021 - 2033
  • 9.4.8. Norway
    • 9.4.8.1. Key country dynamics
    • 9.4.8.2. Competitive scenario
    • 9.4.8.3. Regulatory framework
    • 9.4.8.4. Reimbursement scenario
    • 9.4.8.5. Norway market estimates and forecasts, 2021 - 2033
• 9.5. Asia Pacific
  • 9.5.1. Japan
    • 9.5.1.1. Key country dynamics
    • 9.5.1.2. Competitive scenario
    • 9.5.1.3. Regulatory framework
    • 9.5.1.4. Reimbursement scenario
    • 9.5.1.5. Japan market estimates and forecasts, 2021 - 2033
  • 9.5.2. India
    • 9.5.2.1. Key country dynamics
    • 9.5.2.2. Competitive scenario
    • 9.5.2.3. Regulatory framework
    • 9.5.2.4. Reimbursement scenario
    • 9.5.2.5. India market estimates and forecasts, 2021 - 2033
  • 9.5.3. China
    • 9.5.3.1. Key country dynamics
    • 9.5.3.2. Competitive scenario
    • 9.5.3.3. Regulatory framework
    • 9.5.3.4. Reimbursement scenario
    • 9.5.3.5. China market estimates and forecasts, 2021 - 2033
  • 9.5.4. South Korea
    • 9.5.4.1. Key country dynamics
    • 9.5.4.2. Competitive scenario
    • 9.5.4.3. Regulatory framework
    • 9.5.4.4. Reimbursement scenario
    • 9.5.4.5. South Korea market estimates and forecasts, 2021 - 2033
  • 9.5.5. Australia
    • 9.5.5.1. Key country dynamics
    • 9.5.5.2. Competitive scenario
    • 9.5.5.3. Regulatory framework
    • 9.5.5.4. Reimbursement scenario
    • 9.5.5.5. Australia market estimates and forecasts, 2021 - 2033
  • 9.5.6. Thailand
    • 9.5.6.1. Key country dynamics
    • 9.5.6.2. Competitive scenario
    • 9.5.6.3. Regulatory framework
    • 9.5.6.4. Reimbursement scenario
    • 9.5.6.5. Thailand market estimates and forecasts, 2021 - 2033
• 9.6. Latin America
  • 9.6.1. Brazil
    • 9.6.1.1. Key country dynamics
    • 9.6.1.2. Competitive scenario
    • 9.6.1.3. Regulatory framework
    • 9.6.1.4. Reimbursement scenario
    • 9.6.1.5. Brazil market estimates and forecasts, 2021 - 2033
  • 9.6.2. Argentina
    • 9.6.2.1. Key country dynamics
    • 9.6.2.2. Competitive scenario
    • 9.6.2.3. Regulatory framework
    • 9.6.2.4. Reimbursement scenario
    • 9.6.2.5. Argentina market estimates and forecasts, 2021 - 2033
• 9.7. MEA
  • 9.7.1. South Africa
    • 9.7.1.1. Key country dynamics
    • 9.7.1.2. Competitive scenario
    • 9.7.1.3. Regulatory framework
    • 9.7.1.4. Reimbursement scenario
    • 9.7.1.5. South Africa market estimates and forecasts, 2021 - 2033
  • 9.7.2. Saudi Arabia
    • 9.7.2.1. Key country dynamics
    • 9.7.2.2. Competitive scenario
    • 9.7.2.3. Regulatory framework
    • 9.7.2.4. Reimbursement scenario
    • 9.7.2.5. Saudi Arabia market estimates and forecasts, 2021 - 2033
  • 9.7.3. UAE
    • 9.7.3.1. Key country dynamics
    • 9.7.3.2. Competitive scenario
    • 9.7.3.3. Regulatory framework
    • 9.7.3.4. Reimbursement scenario
    • 9.7.3.5. UAE market estimates and forecasts, 2021 - 2033
  • 9.7.4. Kuwait
    • 9.7.4.1. Key country dynamics
    • 9.7.4.2. Competitive scenario
    • 9.7.4.3. Regulatory framework
    • 9.7.4.4. Reimbursement scenario
    • 9.7.4.5. Kuwait market estimates and forecasts, 2021 - 2033

Chapter 10. Competitive Landscape

• 10.1. Recent Developments & Impact Analysis, By Key Market Participants
• 10.2. Company/Competition Categorization
  • 10.2.1. Innovators
• 10.3. Vendor Landscape
  • 10.3.1. List of key distributors and channel partners
  • 10.3.2. Key customers
  • 10.3.3. Global Key company market share analysis, 2024
  • 10.3.4. Bayer AG
    • 10.3.4.1. Company overview
    • 10.3.4.2. Financial performance
    • 10.3.4.3. Product benchmarking
    • 10.3.4.4. Strategic initiatives
  • 10.3.5. GE Healthcare
    • 10.3.5.1. Company overview
    • 10.3.5.2. Financial performance
    • 10.3.5.3. Product benchmarking
    • 10.3.5.4. Strategic initiatives
  • 10.3.6. Beijing Beilu Pharmaceutical Co., Ltd.
    • 10.3.6.1. Company overview
    • 10.3.6.2. Financial performance
    • 10.3.6.3. Product benchmarking
    • 10.3.6.4. Strategic initiatives
  • 10.3.7. Guerbet
    • 10.3.7.1. Company overview
    • 10.3.7.2. Financial performance
    • 10.3.7.3. Product benchmarking
    • 10.3.7.4. Strategic initiatives
  • 10.3.8. Arco Lifesciences (I) Pvt. Ltd.
    • 10.3.8.1. Company overview
    • 10.3.8.2. Financial performance
    • 10.3.8.3. Product benchmarking
    • 10.3.8.4. Strategic initiatives
  • 10.3.9. Livealth
    • 10.3.9.1. Company overview
    • 10.3.9.2. Financial performance
    • 10.3.9.3. Product benchmarking
    • 10.3.9.4. Strategic initiatives
  • 10.3.10. JB Pharma
    • 10.3.10.1. Company overview
    • 10.3.10.2. Financial performance
    • 10.3.10.3. Product benchmarking
    • 10.3.10.4. Strategic initiatives
  • 10.3.11. Blue Jet Healthcare.
    • 10.3.11.1. Company overview
    • 10.3.11.2. Financial performance
    • 10.3.11.3. Product benchmarking
    • 10.3.11.4. Strategic initiatives
  • 10.3.12. Bracco Diagnostic, Inc.
    • 10.3.12.1. Company overview
    • 10.3.12.2. Financial performance
    • 10.3.12.3. Product benchmarking
    • 10.3.12.4. Strategic initiatives
  • 10.3.13. Fresenius Kabi USA, LLC
    • 10.3.13.1. Company overview
    • 10.3.13.2. Financial performance
    • 10.3.13.3. Product benchmarking
    • 10.3.13.4. Strategic initiatives
  • 10.3.14. Voyageur Pharmaceuticals, Ltd
    • 10.3.14.1. Company overview
    • 10.3.14.2. Financial performance
    • 10.3.14.3. Product benchmarking
    • 10.3.14.4. Strategic initiatives
  • 10.3.15. Grupo Juste
    • 10.3.15.1. Company overview
    • 10.3.15.2. Financial performance
    • 10.3.15.3. Product benchmarking
    • 10.3.15.4. Strategic initiatives
  • 10.3.16. Lantheus Holdings, Inc.
    • 10.3.16.1. Company overview
    • 10.3.16.2. Financial performance
    • 10.3.16.3. Product benchmarking
    • 10.3.16.4. Strategic initiatives
  • 10.3.17. iMAX
    • 10.3.17.1. Company overview
    • 10.3.17.2. Financial performance
    • 10.3.17.3. Product benchmarking
    • 10.3.17.4. Strategic initiatives
  • 10.3.18. Trivitron Healthcare
    • 10.3.18.1. Company overview
    • 10.3.18.2. Financial performance
    • 10.3.18.3. Product benchmarking
    • 10.3.18.4. Strategic initiatives
  • 10.3.19. Jodas Expoim Pvt. Ltd.
    • 10.3.19.1. Company overview
    • 10.3.19.2. Financial performance
    • 10.3.19.3. Product benchmarking
    • 10.3.19.4. Strategic initiatives
• 10.4. Heat Map Analysis/ Company Market Position Analysis
• 10.5. Estimated Company Market Share Analysis, 2025
• 10.6. List of Other Key Market Players